Longevity Health Trades at Lower P/E Ratio Than Peers

Longevity Health's financials and valuation compared to competitors in the medical instruments industry

Feb. 22, 2026 at 8:20pm

Got story updates? Submit your updates here. ›

A comparison of Longevity Health (XAGE) and its peers in the medical instruments industry shows that Longevity Health has lower revenue but higher earnings than its competitors. However, Longevity Health is trading at a lower price-to-earnings ratio, indicating it is more affordable than other companies in the sector. The company also has strong institutional and insider ownership, suggesting long-term growth potential.

Why it matters

This analysis provides investors with a comprehensive look at Longevity Health's financial performance and valuation relative to its industry peers. It highlights the company's competitive positioning and potential opportunities, which could be useful for those considering an investment in Longevity Health or the broader medical instruments sector.

The details

The data shows that Longevity Health's peers have higher revenue but lower earnings per share compared to Longevity Health. However, Longevity Health is trading at a lower price-to-earnings ratio, suggesting it is more affordable than other companies in the industry. Longevity Health also has strong institutional and insider ownership, with 24.2% of shares held by institutions and 29% held by insiders. This indicates that large investors and company leadership believe in the long-term growth potential of the business.

  • The financial data and analysis is current as of February 22, 2026.

The players

Longevity Health

A medical device company focused on developing products to improve longevity and quality of life.

Carmell Therapeutics Corporation

A biopharmaceutical company developing plasma-based bioactive materials to stimulate tissue repair and growth.

Got photos? Submit your photos here. ›

The takeaway

Longevity Health appears to be an attractively valued player in the medical instruments industry, with strong institutional backing and insider ownership suggesting confidence in the company's long-term growth prospects. Investors may want to further research Longevity Health and its competitive positioning as a potential investment opportunity.